Stock Groups

Bayer to invest 2 billion euros in drug production over next 3 years -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: This bridge features the logo of Bayer AG (a German chemical and pharmaceutical manufacturer) in Wuppertal on August 9, 2019. REUTERS/Wolfgang Rattay

FRANKFURT, Reuters – German drugmaker Bayer said that it will invest approximately 2 billion euros (or $22.33 billion) in pharmaceutical manufacturing facilities over the next three year period. This is primarily to increase production of cell and gene therapy drugs as well.

Berkeley, California as well as Berlin and Leverkusen in Germany, are the places to be updated.

Bayer will also move a Brazilian manufacturing plant to Sao Paulo Cancioneiro as well as some infrastructure and services from the German sites of Bergkamen Wuppertal, Berlin, and Wuppertal to new operators.

($1 = 0.8956 euros)

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]